Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Portugal researcher to create 3D cancer disease models

      News
      The Institution of Engineering and Technology (IET) in the UK has awarded a prize fund to a Portuguese researcher for the creation of reliable...

      FDA grants orphan drug status to Shire’s UC treatment SHP647

      FDA Approvals
      The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody, SHP647, for...

      Cancer Genetics and ICON to reduce cancer mortality rate in India

      Americas
      US-based Cancer Genetics (CGI) has collaborated with the Indian Cooperative Oncology Network (ICON) to minimise cancer mortality rates by optimising clinical outcomes for patients...

      Lilly’s Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis

      FDA Approvals
      Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic...

      Sanofi Expects $120 Million Hit As Dengue Vaccine Hits Major Snag

      Europe
      Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can...

      Kyowa Hakko Kirin Submits the Partial Change Approval Application of Mogamulizumab in Japan

      Asia
      Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai; announces the submission of a supplemental application to remove the requirement for...

      Sankyo to Convert Kitasato Daiichi Sankyo Vaccine into Wholly Owned Subsidiary

      Americas
      Daiichi Sankyo Company, Limited announced that its Board of Directors approved a resolution to convert Daiichi Sankyo’s consolidated subsidiary, Kitasato Daiichi Sankyo Vaccine Co.,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.